NCT00360347View on ClinicalTrials.gov

A Study of Mircera in Anemic Patients With Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

November 29, 2001

Primary Completion Date

April 29, 2003

Study Completion Date

April 29, 2003

Conditions

Anemia

Interventions

DRUG

C.E.R.A.

Trial Locations (5)

128 08

Prague

15-276

Bialystok

80-211

Gdansk

20-081

Lublin

02-097

Warsaw

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00360347 - A Study of Mircera in Anemic Patients With Multiple Myeloma | Biotech Hunter | Biotech Hunter